Cephalon Patent Found Invalid In Pay-For-Delay Case
The Pennsylvania federal judge overseeing consolidated suits accusing Cephalon Inc. of conspiring to keep generic versions of its narcolepsy drug Provigil off the market ruled Monday that Apotex Inc. had proven...To view the full article, register now.
Already a subscriber? Click here to view full article